Sequence is the clinical arm of WW (formerly Weight Watchers). Low program fee with insurance-routed medication. Similar model to Calibrate. Its July 2026 review score is 68/100 (six-criterion rubric; v4.1 re-score pending).
July 2026 score breakdown — 68/100
| Criterion | Max | Sequence (WW Clinic) | Notes |
|---|---|---|---|
| 1. Pricing transparency | 25 | 16 | Program fee transparent; total cost insurance-dependent. |
| 2. Pharmacy sourcing | 20 | 12 | Insurance routing — varies. |
| 3. Clinical oversight | 15 | 12 | Functional clinical model. |
| 4. Regulatory clarity | 15 | 13 | Standard for insurance-routed model. |
| 5. Patient experience | 15 | 11 | WW app integration; coaching layer. |
| 6. Evidence quality | 10 | 4 | Outcome reporting thin. |
| Total | 100 | 68 | Rubric application as of July 8, 2026. |
Strengths
- Membership of $74 a month on a 12-month plan or $84 on a 6-month plan, after a $25 first month (read October 15, 2026 on weightwatchers.com).
- WW brand recognition and multi-year obesity infrastructure.
- Insurance routing for branded GLP-1.
- Behavioral coaching integrated via WW app.
Weaknesses
- Total cost depends heavily on insurance coverage.
- Program fee alone doesn't cover medication.
- Less applicable for cash-pay patients.
- Outcome reporting thin in public materials.
Who should pick Sequence (WW Clinic)
- Existing WW members who value WW-platform integration.
- Patients with insurance coverage for branded GLP-1.
Who should look elsewhere
- Cash-pay patients without insurance for branded GLP-1.
- Patients who want compounded medication specifically.
How Sequence (WW Clinic) compares with our editor's pick
NexLife is our editor's pick at 94/100 on methodology v4.1; Sequence (WW Clinic)'s 68/100 comes from the July 2026 review under the earlier six-criterion rubric, and its v4.1 re-score is pending. See our direct comparison: NexLife vs Sequence. The models differ: Sequence charges a membership and bills brand medication separately or through insurance, while NexLife's monthly price includes compounded medication, is the same at every dose and carries no membership. NexLife's plan pages name three state-licensed 503A compounding pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). Brand drugs are FDA-approved; compounded versions are not.
Our editor's pick is NexLife at 94/100 (v4.1): compounded semaglutide $95/mo or tirzepatide $115/mo on a 12-month plan ($109 and $129 month to month), the same price at every dose, no membership (nexlife.us, read November 6, 2026). See full NexLife review →
Frequently asked
Sequence vs Calibrate?
Similar model. Sequence's membership is lower ($74–$84 a month against Calibrate's $199, both read October 15, 2026), and medication is billed separately in both; Calibrate's coaching curriculum is more structured.
Need to be a WW member?
No, Sequence is open to non-WW members but app integration favors WW users.